Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard A Lake

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Molecular and Cellular Biochemistry|July 15, 2005
The immune function of MHC class II molecules mutated in the putative superdimer interfaceJohn D Hayball, Richard A Lake
Nature Reviews. Cancer|May 3, 2005
Immunotherapy and chemotherapy--a practical partnershipRichard A Lake, Bruce W S Robinson
The New England Journal of Medicine|October 14, 2005
Advances in malignant mesotheliomaBruce W S Robinson, Richard A Lake
The New England Journal of Medicine|June 9, 2006
A better way for a cancer cell to dieRichard A Lake, Robbert G van der Most
Molecular Immunology|October 18, 2011
PD-L2 is predominantly expressed by Th2 cellsW Joost Lesterhuis, Henry Steer, Richard A Lake
Science Translational Medicine|March 28, 2014
Comment on "drug discovery: turning the titanic"W Joost Lesterhuis, Anthony Bosco, Richard A Lake
Seminars in Immunopathology|January 29, 2011
Contribution of the immune system to the chemotherapeutic responseAlison M McDonnell, Anna K Nowak, Richard A Lake
Cancer Research|April 17, 2002
Gemcitabine exerts a selective effect on the humoral immune response: implications for combination chemo-immunotherapyAnna K Nowak, Bruce W S Robinson, Richard A Lake
Nutrition and Cancer|February 26, 2014
Dietary vitamin D supplementation does not reduce the incidence or severity of asbestos-induced mesothelioma in a mouse modelCleo Robinson, Samantha Woo, Anna K Nowak, et al.
Cancer Research|August 9, 2003
Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumorsAnna K Nowak, Bruce W S Robinson, Richard A Lake
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Molecular and Cellular Biochemistry|July 15, 2005
The immune function of MHC class II molecules mutated in the putative superdimer interfaceJohn D Hayball, Richard A Lake
Nature Reviews. Cancer|May 3, 2005
Immunotherapy and chemotherapy--a practical partnershipRichard A Lake, Bruce W S Robinson
The New England Journal of Medicine|October 14, 2005
Advances in malignant mesotheliomaBruce W S Robinson, Richard A Lake
The New England Journal of Medicine|June 9, 2006
A better way for a cancer cell to dieRichard A Lake, Robbert G van der Most
Molecular Immunology|October 18, 2011
PD-L2 is predominantly expressed by Th2 cellsW Joost Lesterhuis, Henry Steer, Richard A Lake
Science Translational Medicine|March 28, 2014
Comment on "drug discovery: turning the titanic"W Joost Lesterhuis, Anthony Bosco, Richard A Lake
Seminars in Immunopathology|January 29, 2011
Contribution of the immune system to the chemotherapeutic responseAlison M McDonnell, Anna K Nowak, Richard A Lake
Cancer Research|April 17, 2002
Gemcitabine exerts a selective effect on the humoral immune response: implications for combination chemo-immunotherapyAnna K Nowak, Bruce W S Robinson, Richard A Lake
Nutrition and Cancer|February 26, 2014
Dietary vitamin D supplementation does not reduce the incidence or severity of asbestos-induced mesothelioma in a mouse modelCleo Robinson, Samantha Woo, Anna K Nowak, et al.
Cancer Research|August 9, 2003
Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumorsAnna K Nowak, Bruce W S Robinson, Richard A Lake
Pageof 8